Literature DB >> 20123470

Beyond executive function: non-executive cognitive abilities in individuals with PKU.

Darren Janzen1, Mina Nguyen.   

Abstract

Individuals with early-treated phenylketonuria (ETPKU) most often present with impairment in executive function (EF) and average intelligence compared to the general population. The topic of this review, which is less often discussed, is non-EF impairments that may be associated with ETPKU. Studies that have included assessment of non-EF cognitive functions such as information processing speed, fine motor skills, and perception and visual-spatial abilities suggest that individuals with ETPKU are compromised in these areas. Those assessing non-EF cognitive functions of language skills, long-term memory, and learning skills have yielded mixed results, with some suggesting impairment and others suggesting intact abilities. Although more studies are required, research to date suggests that mechanisms for non-EF deficits may include prefrontal cortex dopamine deficiency and/or white matter abnormalities related to elevated blood phenylalanine levels. For individuals with ETPKU to reach their full potential in life, it is vital to address the challenges associated with EF and non-EF deficits by identifying impairments and appropriate treatment strategies. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20123470     DOI: 10.1016/j.ymgme.2009.10.009

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  16 in total

1.  Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria.

Authors:  Anna Hood; Dorothy K Grange; Shawn E Christ; Robert Steiner; Desirée A White
Journal:  Mol Genet Metab       Date:  2014-01-31       Impact factor: 4.797

2.  Correlation of age-specific phenylalanine levels with intellectual outcome in patients with phenylketonuria.

Authors:  Krista S Viau; Heidi J Wengreen; Sharon L Ernst; Nancy L Cantor; Larissa V Furtado; Nicola Longo
Journal:  J Inherit Metab Dis       Date:  2011-05-10       Impact factor: 4.982

3.  Characterization of phenylalanine hydroxylase gene mutations in phenylketonuria in Xinjiang of China.

Authors:  Wuzhong Yu; Jiang He; Xi Yang; Hongyun Zou; Junhao Gui; Rui Wang; Liu Yang; Zheng Wang; Quan Lei
Journal:  Int J Clin Exp Med       Date:  2014-11-15

4.  cAMP/PKA-CREB-BDNF signaling pathway in hippocampus of rats subjected to chemically-induced phenylketonuria.

Authors:  Cigdem Cicek; Emine Eren-Koçak; Pelin Telkoparan-Akillilar; Muslum Gok; Ebru Bodur
Journal:  Metab Brain Dis       Date:  2021-11-20       Impact factor: 3.584

Review 5.  The neuropsychiatry of inborn errors of metabolism.

Authors:  Mark Walterfang; Olivier Bonnot; Ramon Mocellin; Dennis Velakoulis
Journal:  J Inherit Metab Dis       Date:  2013-05-23       Impact factor: 4.982

6.  Motor development skills of 1- to 4-year-old Iranian children with early treated phenylketonuria.

Authors:  Sepideh Nazi; Farzaneh Rohani; Firoozeh Sajedi; Akbar Biglarian; Arya Setoodeh
Journal:  JIMD Rep       Date:  2013-08-06

7.  Processing speed and executive abilities in children with phenylketonuria.

Authors:  Alicia L Janos; Dorothy K Grange; Robert D Steiner; Desirée A White
Journal:  Neuropsychology       Date:  2012-08-06       Impact factor: 3.295

Review 8.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

9.  Long-term developmental progression in infants and young children taking sapropterin for phenylketonuria: a two-year analysis of safety and efficacy.

Authors:  Nicola Longo; Komudi Siriwardena; Annette Feigenbaum; David Dimmock; Barbara K Burton; Sylvia Stockler; Susan Waisbren; William Lang; Elaina Jurecki; Charlie Zhang; Suyash Prasad
Journal:  Genet Med       Date:  2014-09-18       Impact factor: 8.822

10.  Gender dimorphism in aspartame-induced impairment of spatial cognition and insulin sensitivity.

Authors:  Kate S Collison; Nadine J Makhoul; Marya Z Zaidi; Soad M Saleh; Bernard Andres; Angela Inglis; Rana Al-Rabiah; Futwan A Al-Mohanna
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.